Stockscreener 앱 받기
83.00
0.86%
0.71
시간 외 거래:
83.00
Ani Pharmaceuticals Inc 주식(ANIP)의 최신 뉴스
Insider Sell: Meredith Cook Sells 500 Shares of ANI Pharmaceuticals Inc (ANIP) - GuruFocus
Ani Pharmaceuticals Sr. VP Cook sells $41,015 in stock - Investing.com
ANI Pharmaceuticals (ANIP) VP sells 500 shares under 10b5-1 plan - Stock Titan
Insider Sell: Thomas Haughey Sells 2,000 Shares of ANI Pharmaceu - GuruFocus
Ani Pharmaceuticals director Thomas Haughey sells $161,760 in stock - Investing.com
Ani Pharmaceuticals director Thomas Haughey sells $161,760 in stock By Investing.com - Investing.com India
ANI Pharmaceuticals (ANIP) director awarded 4,357 restricted shares vesting in 2027 - Stock Titan
ANI Pharmaceuticals (ANIP) director receives 4,357-share restricted stock award - Stock Titan
ANI Pharmaceuticals (ANIP) director sells 2,000 shares under plan - Stock Titan
Director Jeanne Thoma receives 4,357-share grant at ANI Pharmaceuticals (ANIP) - Stock Titan
Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings? - Yahoo Finance
ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push - Yahoo Finance
ANIP Pharmaceuticals' Cortrophin Gel Drives 2026 Growth - Yahoo Finance
CenterBook Partners LP Purchases Shares of 19,226 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Ani Pharmaceuticals SVP & CFO Stephen Carey sells $264,960 in stock - Investing.com UK
Ani Pharmaceuticals SVP & CFO Stephen Carey sells $264,960 in stock By Investing.com - Investing.com South Africa
[Form 4] ANI PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
[144] ANI PHARMACEUTICALS INC SEC Filing - Stock Titan
ANI Pharmaceuticals, Inc. $ANIP Stock Holdings Trimmed by Global Alpha Capital Management Ltd. - MarketBeat
ANIP (NASDAQ: ANIP) broker files Form 144 for 11,862-share sale - Stock Titan
How ANI’s Estradiol Gel Recall at ANI Pharmaceuticals (ANIP) Has Changed Its Quality-Control Investment Story - Yahoo Finance
What ANI Pharmaceuticals (ANIP)'s Recall, Raised Guidance and Buybacks Could Mean For Shareholders - Sahm
ANI Pharmaceuticals Revenue Grows 20 Percent in Q1 2026 Financial Results - asatunews.co.id
ANIP Stock Price, Quote & Chart | ANI PHARMACEUTICALS INC (NASDAQ:ANIP) - ChartMill
ANI Pharmaceuticals Inc (ANIP) Stock Down 3.2% -- Now Undervalued? GF Score: 77/100 - GuruFocus
Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term - Yahoo Finance
ANI Pharmaceuticals raises 2026 revenue outlook to $1.08B-$1.14B while launching $100M share repurchase program - MSN
ANI Pharmaceuticals (ANIP) Edges Higher: Approaching Key Resistance LevelsWeak Sell Signals - The Legal Advocate
ANI Pharmaceuticals (ANIP) expected to beat earnings estimates: Should you buy? - MSN
ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference - The Manila Times
Penn Capital Management Company LLC Increases Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals Holds Steady Near Support as Trading Volume EasesBreakout Confirmation - The Legal Advocate
ANI Pharmaceuticals, Inc. $ANIP Shares Sold by Lisanti Capital Growth LLC - MarketBeat
Precision Trading with Ani Pharmaceuticals Inc. (ANIP) Risk Zones - Stock Traders Daily
ANI Pharmaceuticals (ANIP) Q1 earnings: What to expect - MSN
ANI Pharmaceuticals (ANIP) Q1 2026 Earnings: Revenue Beat, Guidance, and Stock DropNews and Statistics - IndexBox
ANI Pharmaceuticals (NASDAQ: ANIP) investors back directors, pay and stock plan - Stock Titan
Barclays Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Maintains Target Price $100 - Moomoo
ANI Pharmaceuticals' (NASDAQ:ANIP) Earnings Are Weaker Than They Seem - Yahoo Finance
ANI Pharmaceuticals Q1 2026 earnings preview - MSN
Profitable Stocks: MYR Group & ANI Pharmaceuticals to Watch, B&G Foods to SellNews and Statistics - IndexBox
ANI Pharmaceuticals (ANIP) shares jump after earnings beat and higher outlook - MSN
Q1 Earnings Outperformers: ANI Pharmaceuticals (NASDAQ:ANIP) And The Rest Of The Pharmaceuticals Stocks - Barchart
How Raised 2026 Guidance And A New Buyback At ANI Pharmaceuticals (ANIP) Has Changed Its Investment Story - Yahoo Finance
ANI Pharmaceuticals Refocuses On Rare Disease As Buybacks And Insider Sales Rise - Yahoo Finance
UBS Group AG Has $11.90 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook - TradingView
ANIP Valuation: Does 9.8x Forward P/E Offer Upside? - TradingView
Ani Pharmaceuticals Insider Sold Shares Worth $1,127,120, According to a Recent SEC Filing - Moomoo
2.11%
자본화:
|
볼륨(24시간):